In Desk

In Desk

6593 posts published

HCM CITY SETS SIGHTS ON BREAKTHROUGH IN SCIENCE AND TECHNOLOGY, DIGITAL TRANSFORMATION
TECHNOLOGY

HCM CITY SETS SIGHTS ON BREAKTHROUGH IN SCIENCE AND TECHNOLOGY, DIGITAL TRANSFORMATION

HCM City has unveiled a comprehensive plan to concentrate on review and investment in its infrastructure, mobilize all resources for breakthroughs in science and technology innovation, and digital transformation. The city's People's Committee, led by Chairperson Phan Văn Miani, emphasized the significance of developing science and technology, innovation, and digital

Variolytics Secures $10 Million Growth Financing Round to Decarbonize Wastewater Sector
TECHNOLOGY

Variolytics Secures $10 Million Growth Financing Round to Decarbonize Wastewater Sector

Hamburg, Germany – Variolytics, a leading wastewater technology company, today announced the successful closing of a significant growth financing round worth millions with Nordic Alpha Partners (NAP), a prominent European venture capital firm. The funding round was also joined by European Innovation Council (EIC), High-Tech Gründerfonds (HTGF), and Fraunhofer Technology Transfer

GENETIC MODIFICATION REGULATION: NEW ZEALAND'S PROPOSAL RAISES CONCERNS OVER INDEPENDENCE AND RESPONSIBILITY
TECHNOLOGY

GENETIC MODIFICATION REGULATION: NEW ZEALAND'S PROPOSAL RAISES CONCERNS OVER INDEPENDENCE AND RESPONSIBILITY

Wellington, New Zealand - A contentious topic has resurfaced in New Zealand's parliament, with the proposed genetic modification bill sparking debate over its implications on public health, safety, and the environment. Despite growing calls for a more modern regulatory framework, concerns have been raised about the potential risks associated with

The article discusses the benefits and potential uses of GLP1-RA (Glucagon-like peptide-1 receptor agonist) drugs, which are used to treat obesity and Type 2 diabetes. These drugs have been shown to have various off-label effects, including:
TECHNOLOGY

The article discusses the benefits and potential uses of GLP1-RA (Glucagon-like peptide-1 receptor agonist) drugs, which are used to treat obesity and Type 2 diabetes. These drugs have been shown to have various off-label effects, including:

Reduced risk of colorectal cancerLower risk of dementiaPotential treatment for addiction disorders, particularly alcohol use disorderPossible neuroprotective effects against Parkinson's diseaseHowever, the article also notes that: The FDA and EMA have concluded that there is no clear link between GLP1-RAs and suicidal or self-injurious thoughts and actions.There have been

Nirmala Sitharaman Announces National Manufacturing Mission to Bolster 'Make In India' Initiative
NATION

Nirmala Sitharaman Announces National Manufacturing Mission to Bolster 'Make In India' Initiative

In a bid to accelerate indigenous manufacturing, Finance Minister Nirmala Sitharaman on Saturday announced the National Manufacturing Mission, paving the way for further growth in the country's 'Make In India' initiative. Presenting the Union Budget 2025-26, Sitharaman outlined several initiatives aimed at fostering sustainable and inclusive economic growth. The flagship